Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Modified Glucose Meters Measure More Than Sugar

By LabMedica International staff writers
Posted on 11 Aug 2011
Point-of-care glucose meters have been adapted for other target molecules by coupling them with a class of molecular sensors called functional DNA sensors. More...


Functional DNA sensors use short segments of DNA that bind to specific targets and a number of functional DNAs and ribonucleic acids (RNAs) are available to recognize a wide variety of targets.

Chemists at the University of Illinois (Urbana-Champaign, IL, USA) modified the meters so that they can be used as simple, portable, inexpensive meters for a number of target molecules in blood, serum, water or food. The DNA segments, immobilized on magnetic particles, are bound to the enzyme invertase, which can catalyze conversion of sucrose to glucose. The user adds a sample of blood, serum, or water to the functional DNA sensor to test for drugs, disease markers, contaminants or other molecules. When the target molecule binds to the DNA, invertase is released into the solution. After removing the magnetic particle by a magnet, the glucose level of the sample rises in proportion to the amount of invertase released, so the user then can employ a glucose meter to quantify the target molecule in the original sample.

The scientists demonstrated using functional DNA with glucose meters to detect cocaine, the disease marker interferon, adenosine, and uranium. The two-step method could be used to detect any kind of molecule that a functional DNA or RNA can bind.

The scientists next plan to further simplify their method, which now requires users to first apply the sample to the functional DNA sensor and then to the glucose meter. Yu Li, PhD, the senior author of the study, said, "We are working on integrating the procedures into one step to make it even simpler. Our technology is new and, given time, it will be developed into an even more user-friendly format.” The study was published on July 24, 2011, in the journal Nature Chemistry.

Related Links:
University of Illinois




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.